143 related articles for article (PubMed ID: 37809373)
1. Ultrasound-targeted semaglutide-loaded PEG-nanoliposomes microbubble destruction protects diabetic cardiomyopathy by activating PI3K/Akt/Nrf2 signaling pathway.
Zhu J; Wang H; Yan C; Li B; Chen B
Heliyon; 2023 Sep; 9(9):e19873. PubMed ID: 37809373
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with ultrasound-targeted microbubble destruction technique and NM-aFGF-loaded PEG-nanoliposomes protects against diabetic cardiomyopathy-induced oxidative stress by activating the AKT/GSK-3β1/Nrf-2 pathway.
Zhang M; Zhu NW; Ma WC; Chen MJ; Zheng L
Drug Deliv; 2020 Dec; 27(1):938-952. PubMed ID: 32611270
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effect of combined use of FGF1-loaded nano-liposomes and ultrasound-targeted microbubble destruction technique on treating rats with experimental diabetic cardiomyopathy].
Zhang M; Zhao YZ; Ma WC; Xu JL; Wang JL; Chen MJ; Yu L; Chen YN
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 May; 45(5):427-433. PubMed ID: 28511329
[No Abstract] [Full Text] [Related]
4. Delivery of astragalus polysaccharide by ultrasound microbubbles attenuate doxorubicin-induced cardiomyopathy in rodent animals.
Liu Y; Chen L; Wu H; Zhang H
Bioengineered; 2022 Apr; 13(4):8419-8431. PubMed ID: 35322740
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Preventive Effect Against Diabetic Cardiomyopathy of FGF1-Loaded Nanoliposomes Combined With Microbubble Cavitation by Ultrasound.
Zheng L; Shen CL; Li JM; Ma YL; Yan N; Tian XQ; Zhao YZ
Front Pharmacol; 2019; 10():1535. PubMed ID: 31998132
[TBL] [Abstract][Full Text] [Related]
6. Using basic fibroblast growth factor nanoliposome combined with ultrasound-introduced technology to early intervene the diabetic cardiomyopathy.
Zhao YZ; Zhang M; Tian XQ; Zheng L; Lu CT
Int J Nanomedicine; 2016; 11():675-86. PubMed ID: 26937188
[TBL] [Abstract][Full Text] [Related]
7. Prevent diabetic cardiomyopathy in diabetic rats by combined therapy of aFGF-loaded nanoparticles and ultrasound-targeted microbubble destruction technique.
Zhao YZ; Zhang M; Wong HL; Tian XQ; Zheng L; Yu XC; Tian FR; Mao KL; Fan ZL; Chen PP; Li XK; Lu CT
J Control Release; 2016 Feb; 223():11-21. PubMed ID: 26712588
[TBL] [Abstract][Full Text] [Related]
8. Advanced Interfere Treatment of Diabetic Cardiomyopathy Rats by aFGF-Loaded Heparin-Modified Microbubbles and UTMD Technique.
Zhang M; Yu WZ; Shen XT; Xiang Q; Xu J; Yang JJ; Chen PP; Fan ZL; Xiao J; Zhao YZ; Lu CT
Cardiovasc Drugs Ther; 2016 Jun; 30(3):247-61. PubMed ID: 26947349
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-targeted microbubble destruction rapidly improves left ventricular function in rats with ischemic cardiac dysfunction.
Cai Q; Li Q; Zhong S; Chen M; Zhong L; Li S; Li H; Chen Y; Wu J
Int J Cardiol; 2024 Jun; 404():131943. PubMed ID: 38458386
[TBL] [Abstract][Full Text] [Related]
10. Baicalein Protects Rats with Diabetic Cardiomyopathy Against Oxidative Stress and Inflammation Injury via Phosphatidylinositol 3-Kinase (PI3K)/AKT Pathway.
Ma L; Li XP; Ji HS; Liu YF; Li EZ
Med Sci Monit; 2018 Aug; 24():5368-5375. PubMed ID: 30070262
[TBL] [Abstract][Full Text] [Related]
11. Shengjie Tongyu Decoction Regulates Cardiomyocyte Autophagy Through Modulating ROS-PI3K/Akt/mTOR Axis by LncRNA H19 in Diabetic Cardiomyopathy.
Wang S; Duan J; Liao J; Wang Y; Xiao X; Li L; Liu Y; Gu H; Yang P; Fu D; Du J; Li X; Shao M
Altern Ther Health Med; 2023 Sep; 29(6):280-287. PubMed ID: 37318892
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of miR-372-3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF-1
Han Z; Zhao D; Han M; Zhang R; Hao Y
Oxid Med Cell Longev; 2022; 2022():4342755. PubMed ID: 36160704
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-targeted microbubble technology facilitates SAHH gene delivery to treat diabetic cardiomyopathy by activating AMPK pathway.
Guo X; Chen K; Ji L; Wang S; Ye X; Xu L; Feng L
iScience; 2024 Feb; 27(2):108852. PubMed ID: 38303706
[TBL] [Abstract][Full Text] [Related]
14. Functional and pathological improvements of the hearts in diabetes model by the combined therapy of bFGF-loaded nanoparticles with ultrasound-targeted microbubble destruction.
Zhao YZ; Tian XQ; Zhang M; Cai L; Ru A; Shen XT; Jiang X; Jin RR; Zheng L; Hawkins K; Charkrabarti S; Li XK; Lin Q; Yu WZ; Ge S; Lu CT; Wong HL
J Control Release; 2014 Jul; 186():22-31. PubMed ID: 24815422
[TBL] [Abstract][Full Text] [Related]
15. Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction.
Tian XQ; Ni XW; Xu HL; Zheng L; ZhuGe DL; Chen B; Lu CT; Yuan JJ; Zhao YZ
Int J Nanomedicine; 2017; 12():7103-7119. PubMed ID: 29026304
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin Gallate Protects Diabetes Mellitus Rats Complicated with Cardiomyopathy through TGF-β1/JNK Signaling Pathway.
Gui L; Wang F; Hu X; Liu X; Yang H; Cai Z; Qi M; Dai C
Curr Pharm Des; 2022; 28(33):2758-2770. PubMed ID: 36173051
[TBL] [Abstract][Full Text] [Related]
17. Effects of PPARγ agonist pioglitazone on cardiac fibrosis in diabetic mice by regulating PTEN/AKT/FAK pathway.
Zhang XD; Sun GX; Guo JJ; Hu CC; Sun RC; Yu HC
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):812-819. PubMed ID: 33577036
[TBL] [Abstract][Full Text] [Related]
18. Novel dual glucagon-like peptide-1/ glucose-dependent insulinotropic polypeptide receptor agonist attenuates diabetes and myocardial injury through inhibiting hyperglycemia, inflammation and oxidative stress in rodent animals.
Wang Y; Cai F; Li G; Tao Y
Bioengineered; 2022 Apr; 13(4):9184-9196. PubMed ID: 35383532
[TBL] [Abstract][Full Text] [Related]
19. Combination of coenzyme Q10-loaded liposomes with ultrasound targeted microbubbles destruction (UTMD) for early theranostics of diabetic nephropathy.
Yue T; Xu HL; Chen PP; Zheng L; Huang Q; Sheng WS; Zhuang YD; Jiao LZ; Chi TT; ZhuGe DL; Liu JJ; Zhao YZ; Lan L
Int J Pharm; 2017 Aug; 528(1-2):664-674. PubMed ID: 28642201
[TBL] [Abstract][Full Text] [Related]
20. Cyp2e1 knockdown attenuates high glucose-induced apoptosis and oxidative stress of cardiomyocytes by activating PI3K/Akt signaling.
Wang J; Yang H; Wang C; Kan C
Acta Diabetol; 2023 Sep; 60(9):1219-1229. PubMed ID: 37195324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
